Our group recently showed that the majority of SARS-CoV-2-specific TSCM cells from convalescent COVID-19 patients are PD-1–TIGIT– cells, suggesting that these cells are not exhausted-like progenitors [124]. This evidence concerns the gene TIGIT and COVID-19.